biomass partnerPharmaceutical Program: Innovative Cannabis-based Therapies 8 • Signed exclusive licensing deal with Dosecann and Avanti RX to co-develop and launch a broad portfolio of pharmaceutical-grade medical products in a mono-dose format • Collaborated with the ONLY health-Canada approved GMP-contract manufacturing facility for QA/QC testing (Avanti-RX) • Biomass Partners include Supreme, Aphria, and TGOD • Agreement provides Delivra with doubledigit royalties and initial cash payments
https://www.delivracorp.com/wp-content/uploads/2017/05/DVA-investor-presentation-2017.pdf
page 8